PolicresulenVaginalSuppository

Manufacturer
Heilongjiang Tianlong Pharmaceutical Co Ltd
Effective date
2024-05-09
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-05-31 21:03:11

Label at a glance#

ProductJujiafenhuangquan Yindaoshuan
Active ingredientPOLICRESULEN
Label structure2 sections

Label contents#

Full prescribing information#

INSTRUCTIONS FOR USE SECTION

78 cases of cervical erosion patients were examined by TCT and HPV, excluded the cervical high intraepithelial lesions and human papillomavirus infection. Then treat with Policresulen Vaginal Suppository. The cervical condition and erosion degree were recorded clearly before treatment. Before sleeping, one suppository was put into the deep vagina, once every other day, two boxes as one course of treatment, three courses of treatment were used continuously, and further consultation at one month after stopping treatment.

Chronic cervicitis is a common disease in married women. It refers to the infiltration of a large number of chronic inflammatory cells such as plasma cells and lymphocytes in the cervical stroma, accompanied by squamous metaplasia and hyperplasia of the cervical gland epithelium and stroma. It is a high risk factor for cervical cancer. Chronic cervicitis can be divided into four pathological types: cervical erosion, cervical polyp, cervical hypertrophy and cervical cyst. The most common pathological type is cervical erosion. Some patients may cause infection, bleeding, cervical stenosis, infertility and other symptoms after the treatment of cervical cryotherapy and microwave. Some patients have certain concerns. From January 2013 to December 2015, our hospital adopted the Policresulen Vaginal Suppository to treat cervical erosion with satisfactory effect. The report is as follows:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CONTENT OF LABELINGCONTENT OF LABELINGPackage LabelPackage LabelInstruction for Usage of Policresulen Vaginal Suppository

Please read the instruction carefully and use the product under the advice of doctor

Warning: during pregnancy, especially in the last three months of pregnancy, any treatment of the cervix should not be used, while the treatment of the vagina and its surrounding areas can only be used when absolutely necessary.

【Name】Policresulen Vaginal Suppository

Pin yin: Jujiafenhuangquan Yindaoshuan

【Ingredients】The main component of this product is Policresulen. Its chemical name is: m-cresol sulfonic acid and formaldehyde polymer.

【Character】This product is light red to light red brown suppository.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
84149-0042-32025-07-29C16284748780-13b156c62-320b-fb37-e063-e6dba90a4e0713040102-aed4-9cb4-e063-6394a90a41bb

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84149-0042-3Jujiafenhuangquan Yindaoshuan8 U in 1 BOXSUPPOSITORY84

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84149-0042JUJIAFENHUANGQUAN YINDAOSHUAN (POLICRESULEN VAGINAL SUPPOSITORY) SUPPOSITORY [HEILONGJIANG TIANLONG PHARMACEUTICAL CO LTD]41 package rows20240510_13040102-aed4-9cb4-e063-6394a90a41bb.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84149-004284149-0042-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
POLICRESULEN6I19M5GB0GACTIM
WATER059QF0KO0RIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
18024571-4506-6d51-e063-6294a90a197213040102-aed4-9cb4-e063-6394a90a41bb2024-05-09Exact identifier
spl id: 18024571-4506-6d51-e063-6294a90a1972
spl set id: 13040102-aed4-9cb4-e063-6394a90a41bb

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.